Search
carbetapentane (Solotuss, Pentoxyverine, Pentoxiverin, Pentoxiverinum, Pentoxyverin, Atussil)
Indications:
- treatment of cough associated with common cold, influenza, bronchitis or sinusitis
Contraindications:
- not effective in treatment of cough due to smoking or chronic obstructive pulmonary disease (COPD)
- use of MAO inhibitor within 14 days
Dosage:
- 6 mg/mL oral suspension
Adverse effects:
- hypersensitivity
- angioedema
- palpitations, tachycardia, cardiac arrhythmia
- confusion
- hallucinations
- respiratory suppression
- nausea, vomiting
- dyspepsia
- dizziness
- drowsiness
- insomnia
- rash
Drug interactions:
- carbetapentane can inhibit metabolism of MAO inhibitors
Mechanism of action:
- cough suppressant
Interactions
drug adverse effects of antitussive agent(s)
General
antitussive agent
Database Correlations
PUBCHEM cid=2562
References
- eMedicinehealth
http://www.emedicinehealth.com/drug-carbetapentane/article_em.htm
Component-of
brompheniramine/carbetapentane/phenylephrine
carbetapentane/carbinoxamine/phenylephrine
carbetapentane/chlorpheniramine
carbetapentane/chlorpheniramine/ephedrine/phenylephrine
carbetapentane/chlorpheniramine/phenylephrine
carbetapentane/citrate/dexchlorpheniramine/phenylephrine
carbetapentane/citrate/guaifenesin
carbetapentane/citrate/guaifenesin/phenylephrine
carbetapentane/citrate/pseudoephedrine
carbetapentane/citrate/pseudoephedrine/pyrilamine
carbetapentane/dexchlorpheniramine/phenylephrine
carbetapentane/diethylcarbamazine/guaifenesin/phenylephrine
carbetapentane/diphenhydramine
carbetapentane/diphenhydramine/phenylephrine
carbetapentane/guaiacolsulfonate/phenylephrine
carbetapentane/guaifenesin
carbetapentane/guaifenesin/phenylephrine
carbetapentane/guaifenesin/pseudoephedrine
carbetapentane/phenylephrine
carbetapentane/phenylephrine/pyrilamine
carbetapentane/pseudoephedrine
carbetapentane/pseudoephedrine/pyrilamine